Hi Key Sole
Earlier approval for the tests would have been a great boon, and other players in the testing space have limited sales of GSS kits. Not saying there has been no positive upside, just that it could have been so much better had a few things gone more favourably the way of the company. I see strength in the diversification of their testing.
- Forums
- ASX - By Stock
- GSS
- Ann: First quarter sales update
GSS
genetic signatures limited
Add to My Watchlist
0.00%
!
36.5¢

Ann: First quarter sales update, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
36.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.90M |
Open | High | Low | Value | Volume |
36.5¢ | 36.5¢ | 36.5¢ | $657 | 1.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 11082 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 45991 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 11082 | 0.365 |
3 | 10907 | 0.360 |
4 | 130509 | 0.350 |
1 | 1683 | 0.300 |
1 | 25000 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 45991 | 2 |
0.390 | 20000 | 1 |
0.400 | 111918 | 2 |
0.420 | 40000 | 2 |
0.455 | 5000 | 1 |
Last trade - 10.22am 08/07/2025 (20 minute delay) ? |
Featured News
GSS (ASX) Chart |